iifl-logo

Nippon India Pharma Fund Direct Bonus

Nippon India Pharma Fund Direct Bonus

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Pharma Fund Direct Bonus

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

01-Jan-2013

Fund Manager

Sailesh Raj Bhan

Net Assets (Rs. cr)

8352.16

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Pharma Fund Direct Bonus - Nav Details

Nav Date

:  27-Jun-2025

NAV [Rs.]

:  576.5554

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Exit Load %

Nippon India Pharma Fund Direct Bonus- NAV Chart

Nippon India Pharma Fund Direct Bonus- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
2.05
1.68
6.14
-0.16
16.65
26.26
22.91
18.26
Category Avg
1.89
1.69
4.95
-2.1
17.82
25.81
22.2
17.79
Category Best
2.96
2.66
12.9
1.96
29.11
30.63
25.34
35.69
Category Worst
0.34
0.73
0.8
-6.37
5.63
20.99
16.92
-4.55

Nippon India Pharma Fund Direct Bonus- Latest Dividends

No Records Found

Nippon India Pharma Fund Direct Bonus- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Krishna Institu.4,61,785

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.5762563491,049.56
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.491198808792.65
EquityLupinPharmaceuticals & Biotechnology5.822483991486.29
EquityCiplaPharmaceuticals & Biotechnology5.623200000469.02
EquityDr Reddy's LabsPharmaceuticals & Biotechnology5.493662170458.21
EquityApollo HospitalsHealthcare Services5.34648795446.40
EquityMedplus HealthRetailing4.203627277350.54
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology3.73943731311.29
EquityVijaya Diagnost.Healthcare Services3.242831564270.78
EquityNarayana HrudayaHealthcare Services2.941406946245.35
EquityGland PharmaPharmaceuticals & Biotechnology2.911529352242.95
EquityAjanta PharmaPharmaceuticals & Biotechnology2.88959323240.86
EquityAbbott IndiaPharmaceuticals & Biotechnology2.8778677239.61
EquityDr Lal PathlabsHealthcare Services2.37709112197.60
EquityAurobindo PharmaPharmaceuticals & Biotechnology2.341702630195.42
EquityMankind PharmaPharmaceuticals & Biotechnology2.24757496186.92
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.232000632186.05
EquityThyrocare Tech.Healthcare Services2.221765838185.27
EquityPfizerPharmaceuticals & Biotechnology2.14318249178.64
EquityJ B Chemicals &Pharmaceuticals & Biotechnology2.01999649167.57
EquityAlkem LabPharmaceuticals & Biotechnology1.98323678165.02
EquitySanofi IndiaPharmaceuticals & Biotechnology1.71230272142.59
EquitySai LifePharmaceuticals & Biotechnology1.401545179116.96
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.35213659112.56
EquityIpca Labs.Pharmaceuticals & Biotechnology1.34785412111.90
EquitySuraksha Diagno.Healthcare Services1.223169618101.77
EquityTorrent Pharma.Pharmaceuticals & Biotechnology1.1530336496.30
EquityFortis Health.Healthcare Services0.93110388977.96
EquityBioconPharmaceuticals & Biotechnology0.92228422276.71
EquitySyngene Intl.Healthcare Services0.87112479572.72
EquityEmcure PharmaPharmaceuticals & Biotechnology0.7547027262.54
EquityAstrazeneca PharPharmaceuticals & Biotechnology0.616407851.08
EquityAkums DrugsPharmaceuticals & Biotechnology0.5783371847.63
EquityIndoco RemediesPharmaceuticals & Biotechnology0.55183492445.99
EquityOrchid PharmaPharmaceuticals & Biotechnology0.3749272730.98
EquityConcord BiotechPharmaceuticals & Biotechnology0.2311173819.53
Cash & Cash Equivalent
Reverse RepoTREPS-/-1.520127.29
Cash & Cash EquivalentC C I-/-0.0000.06
Net CA & OthersNet CA & Others-/--0.120-8.58

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.